TGF-β signaling and the fibrotic response
The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.
Abstract
The cause of fibrotic diseases, pathologies characterized by excessive production, deposition, and contraction of extracellular matrix, is unknown. To understand the molecular basis of fibrotic disease, it is essential to appreciate how matrix deposition is normally controlled and how this process is dysregulated in fibrogenesis. This review discusses the current state of knowledge concerning interactions among the profibrotic proteins transforming growth factor‐β (TGF‐β), connective tissue growth factor (CTGF, CCN2), and ED‐A fibronectin (ED‐A FN) and the antifibrotic proteins tumor necrosis factor‐α (TNF‐α) and γ‐interferon (IFN‐γ).—Leask, A., Abraham, D. J. TGF‐β signaling and the fibrotic response. FASEB J. 18, 816–827 (2004)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGF-β is the critical mediator of pathological fibrosis after myocardial injury [64].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [64]
In the citing paper
“TNFα also suppresses the TGFβ stimulation of ECM production.62”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [62]
Citations
Cites
1 retracted
RETRACTED: Deficient Smad7 expression: A putative molecular defect in scleroderma
Dong, C., Zhu, S., Wang, T., Yoon, W., Li, Z., Alvarez, R. J., ten Dijke, P., White, B., Wigley, F. M., & Goldschmidt-Clermont, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062010399 · Cited by 244 · cited 1×
“Although one report showed decreased levels of the inhibitory Smad7 in scleroderma fibroblasts (94), two other studies showed no difference in Smad7 levels between normal and scleroderma fibroblasts (65, 91); thus, Smad7 deficiency does not seem to be a general feature of scleroderma fibroblasts.”
ResultRetractedMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556 · cited 4×
“The TGF- superfamily includes nearly 30 proteins in mammals including TGF- s, activins and inhibins, nodal, myostatin, bone morphogenetic proteins (BMPs), growth/differentiation factors (GDFs), and anti-Müllerian hormone (AMH, also called Müllerianinhibiting substance or MIS) (15, 16).”
BackgroundInfluentialDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 2×
“Transcriptional responses induced by IFN- in most cells are mediated through the Jak-Stat pathway (146).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 1×
“IFN- , a pleiotropic cytokine produced by T cells and NK cells, plays fundamental roles in innate and acquired immune responses (145).”
BackgroundYu, Q., & Stamenkovic, I. (2000) · PubMed Central · Cited by 2,203
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076 · cited 1×
“TSP-1 null mice demonstrate a partial phenotypic overlap with TGF- 1 null animals (30), and integrin 6 / are highly resistant to lung fibrosis induced by the profibrotic drug bleomycin (31).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754 · cited 1×
“For example, the plasmin proteases MMP-2 and -9, which promote matrix degradation (24), activate TGF- (25, 26).”
BackgroundThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · cited 5×
“observed in lesions of fibrotic disease (2).”
BackgroundInfluentialMaking sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Research works printed but not linked: 3
- 10.1111/j.1523-1755.2002.kid567.x · doi:10.1111/j.1523-1755.2002.kid567.x · Paper page
- Schmid P., 1998, Enhanced expression oftransforming growth factor-beta type and type II receptors in wound granulation tissue and hyper trophic scar, Am. J. Pathol., 152, 485
- 10.1111/j.1523-1755.1998.00820.x · doi:10.1111/j.1523-1755.1998.00820.x · Paper page
Cited by
Items 201–300 of 1,008
CCN2 Is Necessary for Adhesive Responses to Transforming Growth Factor-β1 in Embryonic Fibroblasts
Shi-wen, X., Stanton, L. A., Kennedy, L., Pala, D., Chen, Y., Howat, S. L., Renzoni, E. A., Carter, D. E., Bou-Gharios, G., Stratton, R. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511343200 · Cited by 150
Self-citationUnravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffness
Remst, D. F. G., Davidson, E. N. B., & van der Kraan, P. M. (2015) · Rheumatology · doi:10.1093/rheumatology/kev228 · Cited by 150
Current concepts related to hypertrophic scarring in burn injuries
Chiang, R. S., Borovikova, A. A., King, K., Banyard, D. A., Lalezari, S., Toranto, J. D., Paydar, K. Z., Wirth, G. A., Evans, G. R. D., & Widgerow, A. D. (2016) · Wound Repair and Regeneration · doi:10.1111/wrr.12432 · Cited by 166
Sargent, J. L., Milano, A., Bhattacharyya, S., Varga, J., Connolly, M. K., Chang, H. Y., & Whitfield, M. L. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.318 · Cited by 149
Nakanishi, H., Sugiura, T., Streisand, J. B., Lonning, S. M., & Roberts, J. D. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00389.2006 · Cited by 149
Fuchshofer, R., Yu, A. H. L., Welge-Lu¨ssen, U., & Tamm, E. R. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0226 · Cited by 151
Zhou, Y., Lee, J.-Y., Lee, C.-M., Cho, W.-K., Kang, M.-J., Koff, J. L., Yoon, P.-O., Chae, J., Park, H.-O., Elias, J. A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356824 · Cited by 143
“TGF- family proteins are multifunctional cytokines that have been implicated in diverse biologic processes including cell growth and survival, cell and tissue differentiation, development, inflammation, immunity, hematopoiesis, and tissue remodeling and repair (5).”
BackgroundCorneal myofibroblasts and fibrosis
Wilson, S. E. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108272 · Cited by 153
Norona, L. M., Nguyen, D. G., Gerber, D. A., Presnell, S. C., & LeCluyse, E. L. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw169 · Cited by 144
Influence of Endothelial Cells on Vascular Smooth Muscle Cells Phenotype after Irradiation
Milliat, F., François, A., Isoir, M., Deutsch, É., Tamarat, R., Tarlet, G., Atfi, A., Validire, P., Bourhis, J., Sabourin, J., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060116 · Cited by 145
Klass, B. R., Grobbelaar, A. O., & Rolfe, K. J. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.069831 · Cited by 168
Primary Cilia Deletion in Pancreatic Epithelial Cells Results in Cyst Formation and Pancreatitis
Cano, D. A., Sekine, S., & Hebrok, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.050 · Cited by 155
Ricucci, D., Loghin, S., Lin, L. M., Spångberg, L. S. W., & Tay, F. R. (2014) · Journal of Dentistry · doi:10.1016/j.jdent.2014.06.012 · Cited by 144
Targeting inflammatory pathways for tumor radiosensitization
Deorukhkar, A., & Krishnan, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.039 · Cited by 151
“The TGF-β family regulates a range of processes, including embryonic development, homeostasis, cell cycle control and wound healing [190] and its dysregulation has been associated with carcinogenesis.”
BackgroundMolecular networks underlying myofibroblast fate and fibrosis
Stempien-Otero, A., Kim, D.-H., & Davis, J. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.05.002 · Cited by 143
Keloid disorder: Fibroblast differentiation and gene expression profile in fibrotic skin diseases
Macarak, E. J., Wermuth, P. J., Rosenbloom, J., & Uitto, J. (2021) · Experimental Dermatology · doi:10.1111/exd.14243 · Cited by 139
Cushing, M. C., Mariner, P. D., Liao, J., Sims, E. A., & Anseth, K. S. (2008) · The FASEB Journal · doi:10.1096/fj.07-087627 · Cited by 139
Gressner, O. A., Lahme, B., Demirci, I., Gressner, A. M., & Weiskirchen, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.05.015 · Cited by 144
Wnt Signaling in Skeletal Muscle Dynamics: Myogenesis, Neuromuscular Synapse and Fibrosis
Cisternas, P., Henríquez, J. P., Brandan, E., & Inestrosa, N. C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8540-5 · Cited by 157
Kolosova, I., Nethery, D., & Kern, J. A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22448 · Cited by 135
“Fibronectin is another component of ECM that enhances the profibrotic effects of TGF-b1 (Leask and Abraham, 2004), possibly by effecting the formation of collagen fibrils (Kadler et al., 2008).”
BackgroundThe Role of TGF-β2 and Bone Morphogenetic Proteins in the Trabecular Meshwork and Glaucoma
Wordinger, R. J., Sharma, T. P., & Clark, A. F. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0220 · Cited by 142
Potential Role of Rho-Associated Protein Kinase Inhibitor Y-27632 in Glaucoma Filtration Surgery
Honjo, M., Tanihara, H., Kameda, T., Kawaji, T., Yoshimura, N., & Araie, M. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0878 · Cited by 150
A review of current and novel therapies for idiopathic pulmonary fibrosis.
Rafii, R., Juarez, M. M., Albertson, T. E., & Chan, A. L. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2012.12.07 · Cited by 175
Matsuzaki, S., & Darcha, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076808 · Cited by 138
Labib, S., Williams, A., Yauk, C. L., Nikota, J. K., Wallin, H., Vogel, U. B., & Halappanavar, S. S. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0125-9 · Cited by 145
“This signaling leads to the production of growth factors, such as TGF-β, which are key regulators of fibroblast activity, and their increased expression disrupts normal homeostatic collagen metabolism, resulting in the excessive collagen deposition in the extracellular matrix characteristic of fibrotic lesions [66, 71…”
BackgroundRegulation of fibrosis in muscular dystrophy
Smith, L., & Barton, E. R. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.014 · Cited by 152
YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells
Chuyi, Z., Zhu, X., Hua, Y., Zhao, Q., Wang, K., Zhen, L., Wang, G., Lü, J., Luo, A., Cho, W. C. S., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1223-7 · Cited by 151
Chen, Y., Shiwen, X., Beek, J. V., Kennedy, L., McLeod, M. R., Renzoni, E. A., Bou–Gharios, G., Wilcox‐Adelman, S. A., Goetinck, P. F., Eastwood, M., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61252-7 · Cited by 150
“Although TGF principally signals through Smads, recent data has shown that ras/MEK/ERK MAP kinase cascade modifies TGF signaling.(7) For example, the TGF induction of CCN2 in mesangial cells and fibroblasts requires ras/MEK/ERK.”
ResultSelf-citationLiu, X., Sun, S. Q., Hassid, A., & Ostrom, R. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028951 · Cited by 155
“However, TGF- /Smad signaling is tightly controlled by MAP kinase signaling cascades, particularly ERK1/2, in many cell types (Yue and Mulder, 2000; Leask and Abraham, 2004). de Caestecker et al. (1998) showed that hepatic growth factor and epidermal growth factor, which activate the MEK/ERK…”
BackgroundInfluentialModulation of extracellular matrix turnover in the trabecular meshwork
Fuchshofer, R., & Tamm, E. R. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.01.005 · Cited by 150
Regulation of hepatic stellate cells by connective tissue growth factor
Huang, G. (2012) · Frontiers in Bioscience · doi:10.2741/4067 · Cited by 135
Vitamin C in Stem Cell Biology: Impact on Extracellular Matrix Homeostasis and Epigenetics
D'Aniello, C., Cermola, F., Patriarca, E. J., & Minchiotti, G. (2017) · Stem Cells International · doi:10.1155/2017/8936156 · Cited by 129
Bone marrow‐derived mesenchymal stem cell attenuates skin fibrosis development in mice
Wu, Y., Huang, S., Jirigala, E., Ma, K., Yang, S., Sun, T.-Z., & Fu, X. (2013) · International Wound Journal · doi:10.1111/iwj.12034 · Cited by 134
Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action
Elufioye, T. O., & Habtemariam, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108600 · Cited by 140
Role of oxidative stress in chemical allergens induced skin cells activation
Corsini, E., Galbiati, V., Nikitovic, D., & Tsatsakis, A. M. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.02.038 · Cited by 141
“On the other hand, in inflamed tissues, both ECM turnover and protease secretion by tissue-resident cells are affected by cytokines, including TGF-b (Leask and Abraham, 2004), IL-13 (Purwar et al.”
BackgroundNF‐κB mediated miR‐26a regulation in cardiac fibrosis
Wei, C., Kim, I., Kumar, S., Jayasinghe, S., Hong, N., Castoldi, G., Catalucci, D., Jones, W. K., & Gupta, S. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24296 · Cited by 139
“…including cardiac fibrosis (Oemar et al., 1997; Matsui and Sadoshima, 2004; Dean et al., 2005) and is suggested to play a role in the extracellular matrix deposition as an important downstreammediator of transforming growth factor-b (TGF-b (Moussad and Brigstock, 2000; Leask and Abraham, 2004).”
BackgroundJun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-β1
Alcorn, J. F., Guala, A. S., van der Velden, J., McElhinney, B., Irvin, C. G., Davis, R. J., & Janssen-Heininger, Y. M. W. (2008) · Journal of Cell Science · doi:10.1242/jcs.019455 · Cited by 124
“The extent of fibrosis has been directly linked with poor prognosis in various human diseases (Elias et al., 1999), and the functional importance of TGF-β1 herein has been highlighted (Leask and Abraham, 2004).”
BackgroundBugyei‐Twum, A., Advani, A., Advani, S. L., Zhang, Y., Thai, K., Kelly, D. J., & Connelly, K. A. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-89 · Cited by 135
FERRINI, M. G., KOVANECZ, I., NOLAZCO, G., RAJFER, J., & GONZALEZ‐CADAVID, N. F. (2006) · BJU International · doi:10.1111/j.1464-410x.2006.05955.x · Cited by 132
Del Galdo, F., Lisanti, M. P., & Jimenez, S. A. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283103d27 · Cited by 131
Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis
Krishnan, A., Li, X., Kao, W.-Y., Viker, K., Butters, K., Masuoka, H., Knudsen, B., Gores, G., & Charlton, M. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.121 · Cited by 135
Zehender, A., Huang, J., Györfi, A.-H., Matei, A.-E., Trinh-Minh, T., Xu, X., Li, Y.-N., Chen, C.-W., Lin, J., Dees, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05768-3 · Cited by 126
Yang, F., Leung, V., Luk, K. D. K., Chan, D. T.-M., & Cheung, K. (2009) · The Journal of Pathology · doi:10.1002/path.2519 · Cited by 131
Liu, S., Shi-wen, X., Kennedy, L., Pala, D., Chen, Y., Eastwood, M., Carter, D. E., Black, C. M., Abraham, D. J., & Leask, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-12-1121 · Cited by 126
“TGF also induces ECM synthesis and remodeling and myofibroblast differentiation (Leask and Abraham, 2004).”
BackgroundInfluentialSelf-citationRead, C., Nyimanu, D., Williams, T. L., Huggins, D. J., Šulentić, P., Macrae, R. G. C., Yang, P. B., Glen, R. C., Maguire, J. J., & Davenport, A. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017533 · Cited by 140
“In addition to its involvement in renal fibrosis, TGFb is known to have roles in numerous fibrotic mechanisms (Leask and Abraham, 2004), including in the myocardium (Koitabashi et al., 2011).”
BackgroundLee, T.-H., Yeh, C., Lee, Y.-T., Shih, Y.-C., Chen, Y.-T., Hung, C., You, M.-Y., Wu, P., Shentu, T., Huang, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18047-x · Cited by 135
Augustus, A. S., Buchanan, J., Park, T.-S., Hirata, K., Noh, H.-L., Sun, J., Homma, S., D'armiento, J., Abel, E. D., & Goldberg, I. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509890200 · Cited by 128
Transforming growth factor beta (TGFβ) and keloid disease
Jagadeesan, J., & Bayat, A. (2006) · International Journal of Surgery · doi:10.1016/j.ijsu.2006.04.007 · Cited by 144
The lens as a model for fibrotic disease
ELDRED, J., Dawes, L. J., & Wormstone, I. M. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0341 · Cited by 143
Experimental models for posterior capsule opacification research
Wormstone, I. M., & Eldred, J. A. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.04.021 · Cited by 129
Shi, J., Guan, H., Shi, S. R., Cai, W., Bai, X.-Z., Hu, X., Fang, X., Liu, J., Tao, K., Zhu, X., et al. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1314-0 · Cited by 129
“Consistent with this consensus, it has been accepted that the persistence of abundant myofibroblasts in the wound is a feature of fibrosis [18].”
BackgroundRemst, D. F. G., Blom, A. B., Vitters, E. L., Bank, R. A., van den Berg, W. B., Davidson, E. N. B., & van der Kraan, P. M. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38266 · Cited by 129
“A key event in the onset of fibrosis is the response of fibroblasts to transforming growth factor (TGF ) (4).”
BackgroundA Novel Modulatory Mechanism of Transforming Growth Factor-β Signaling through Decorin and LRP-1
Cabello-Verrugio, C., & Brandan, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700243200 · Cited by 127
Role of keratinocyte–fibroblast cross‐talk in development of hypertrophic scar
Ghahary, A., & Ghaffari, A. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00225.x · Cited by 143
Mishra, R., Cool, B. L., Laderoute, K. R., Foretz, M., Viollet, B., & Simonson, M. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800902200 · Cited by 135
González, D., Contreras, O., Rebolledo, D. L., Espinoza, J. P., van Zundert, B., & Brandan, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177649 · Cited by 136
Lenti, M. V., & Sabatino, A. D. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.10.003 · Cited by 135
Pechkovsky, D. V., Prêle, C. M., Wong, J., Hogaboam, C. M., McAnulty, R. J., Laurent, G. J., Zhang, S. S.-M., Selman, M., Mutsaers, S. E., & Knight, D. A. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.12.022 · Cited by 127
Chun, J. N., Cho, M., So, I., & Jeon, J. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.06.014 · Cited by 132
TGFβ, smooth muscle cells and coronary artery disease: a review
Low, E. L., Baker, A. H., & Bradshaw, A. C. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.09.004 · Cited by 134
Targeting the TGFβ, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma
Leask, A. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.01.006 · Cited by 137
Self-citationAntisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
Fusco, D. D., Dinallo, V., Marafini, I., Figliuzzi, M. M., Romano, B., & Monteleone, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00305 · Cited by 126
“Although TGF-β1 is known to be pro-fibrogenic (Leask and Abraham, 2004; Vallance et al., 2005), no patient recruited into the trial developed strictures (Zorzi et al., 2012).”
BackgroundAngiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation
Carvajal, G., Rodríguez‐Vita, J., Rodrigues‐Díez, R., Sánchez‐López, E., Rupérez, M., Cartier, C., Esteban, V., Ortíz, A., Egido, J., Mezzano, S. A., et al. (2008) · Kidney International · doi:10.1038/ki.2008.213 · Cited by 126
p38 Inhibitors Prevent TGF-β–Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts
Meyer-ter-Vehn, T., Gebhardt, S., Sebald, W., Buttmann, M., Grehn, F., Schlunck, G., & Knaus, P. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0361 · Cited by 125
Epithelial-mesenchymal transition in liver fibrosis
ZHAO, Y.-L., ZHU, R.-T., & SUN, Y.-L. (2016) · Biomedical Reports · doi:10.3892/br.2016.578 · Cited by 123
Fibrosis Is a Key Inhibitor of Lymphatic Regeneration
Avraham, T., Clavin, N. W., Daluvoy, S. V., Fernandez, J., Soares, M. A., Cordeiro, A. P., & Mehrara, B. J. (2009) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3181adcf4b · Cited by 122
Cytokines and radiation-induced pulmonary injuries
Lierová, A., Jeličová, M., Němcová, M., Prokšová, M., Pejchal, J., Zárybnická, L., & Šinkorová, Z. (2018) · Journal of Radiation Research · doi:10.1093/jrr/rry067 · Cited by 149
“It can be activated by various physico-chemical treatments or by proteases [104].”
BackgroundThe extracellular matrix of the dermis: flexible structures with dynamic functions
Krieg, T. M., & Aumailley, M. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01313.x · Cited by 142
Inhibition of Allergen-Induced Airway Remodeling in Smad 3-Deficient Mice
Le, A. V., Cho, J. Y., Miller, M., McElwain, S., Golgotiu, K., & Broide, D. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7310 · Cited by 124
“The profibrotic cytokine, TGF- , and its close homolog, activin A, both of which activate cellular responses through the Smad signaling pathway, are hypothesized to play an essential role in promoting the structural changes of tissue remodeling (2).”
BackgroundBonderman, D., Jakowitsch, J., Redwan, B., Bergmeister, H., Renner, M.-K., Panzenboeck, A., Adlbrecht, C., Georgopoulos, A. P., Klepetko, W., Kneußl, M., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.156000 · Cited by 124
Zhong, Z., Carroll, K. D., Policarpio, D., Osborn, C., Gregory, M., Bassi, R., Jimenez, X., Prewett, M., Liebisch, G., Persaud, K., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1634 · Cited by 123
Davies, R. J., Holmes, A. M., Deighton, J., Long, L., Yang, X., Barker, L., Walker, C., Budd, D. C., Upton, P. D., & Morrell, N. W. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00309.2011 · Cited by 128
Nakashita, T., Ando, K., Kaneko, N., Takahashi, K., & Motojima, S. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005615 · Cited by 127
Tissue transglutaminase (TG2) - a wound response enzyme
Telci, D., & Griffin, M. (2006) · Frontiers in bioscience · doi:10.2741/1843 · Cited by 141
Junglas, B., Yu, A. H. L., Welge‐Lüßen, U., Tamm, E. R., & Fuchshofer, R. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.01.008 · Cited by 123
“CTGF has been identified as a critical downstream mediator of the fibrogenic action of TGF-b2 (Ihn, 2002; Leask and Abraham, 2004) which itself induces the expression of CTGF (Fuchshofer et al., 2005; Yang et al., 1998).”
BackgroundOdorisio, T., Salvio, M. D., Orecchia, A., Zenzo, G. D., Piccinni, E., Cianfarani, F., Travaglione, A., Uva, P., Bellei, B., Conti, A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu102 · Cited by 130
Transforming growth factor-β signaling through the Smad proteins: Role in systemic sclerosis
Verrecchia, F., Mauviel, A., & Farge, D. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.06.001 · Cited by 125
“TGF-β has been implicated as being an important mediator in a number of fibrotic diseases [17,18].”
BackgroundDavis, G. E., & Saunders, W. B. (2006) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsymp.5650008 · Cited by 129
“Considerable further study is necessary here to investigate how factors such as transforming growth factor (TGF)-b, angiopoietins and HB-EGF affect these stabilizing events since the levels of these factors are modulated and regulated by EC–pericyte interactions and play an important role in vascular stabilization (Hi…”
BackgroundVial, C., Zúñiga, L. M., Cabello‐Verrugio, C., Cañón, P., Fadic, R., & Brandan, E. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21324 · Cited by 118
“It also stimulates the expression of connective tissue growth factor (CTGF/CCN2) (Holmes et al., 2001) a cytokine that is responsible for TGF-b fibrotic activity (Grotendorst, 1997; Leask and Abraham, 2004).”
BackgroundInflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review
Asatryan, B., Asimaki, A., Landstrom, A. P., Khanji, M. Y., Odening, K. E., Cooper, L. T., Marchlinski, F. E., Gelzer, A. R., Semsarian, C., Reichlin, T., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.055890 · Cited by 120
3D in vitro M2 macrophage model to mimic modulation of tissue repair
Sapudom, J., Karaman, S., Mohamed, W. K. E. A., Garcia‐Sabaté, A., Quartey, B. C., & Teo, J. C. M. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00193-5 · Cited by 130
In Vitro Evidence for a Direct Antifibrotic Role of the Immunosuppressive Drug Mycophenolate Mofetil
Roos, N., Poulalhon, N., Farge, D., Madelaine, I., Mauviel, A., & Verrecchia, F. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117051 · Cited by 123
“…and cell-adhesive functions of the microcirculation), and activation of resident mesenchymal cells (e.g., fibroblasts, endothelial cells, pericytes), leading to excessive collagen deposition and ECM contraction (Uitto and Kouba, 2000; Verrecchia and Mauviel, 2002a,b; Leask and Abraham, 2004).”
BackgroundYao, Q., Xu, B., Wang, J., Liu, H., Zhang, S., & Tu, C. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-156 · Cited by 131
“Therefore, TGF-β1 has been regarded as the master cytokine in liver fibrogenesis [2,3,6].”
BackgroundInfluentialHamburg‐Shields, E., DiNuoscio, G. J., Mullin, N. K., Lafyatis, R., & Atit, R. P. (2015) · The Journal of Pathology · doi:10.1002/path.4481 · Cited by 112
“We next investigated potential crosstalk between stabilized β-catenin and canonical TGFβ signalling, which is the prototypic pro-fibrotic signalling pathway [41].”
BackgroundPlakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes
Dubash, A. D., Kam, C. Y., Aguado, B. A., Patel, D. M., Delmar, M., Shea, L. D., & Green, K. J. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201507018 · Cited by 113
“TGF-β1 is well known as a potent profibrotic cytokine that induces robust ECM production (Leask and Abraham, 2004; Leask, 2007; Biernacka et al., 2011; Dobaczewski et al., 2011).”
BackgroundBelmadani, S., Bernal, J., Wei, C., Pallero, M. A., Dell’Italia, L. J., Murphy-Ullrich, J. E., & Berecek, K. H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070056 · Cited by 122
“The potent fibrogenic action of TGF- is regulated at multiple levels, including protein expression and secretion, localization to the extracellular matrix, and modulation of receptor and signaling pathways.(23,24) TGF- is secreted as a latent complex that must be activated to elicit fibrogenic effects.”
BackgroundPathogenesis of pleural fibrosis
Mutsaers, S. E., Prêle, C. M., Brody, A. R., & Idell, S. (2004) · Respirology · doi:10.1111/j.1440-1843.2004.00633.x · Cited by 129
Miller, C. L., Cai, Y., Oikawa, M., Thomas, T., Dostmann, W. R., Zaccolo, M., Fujiwara, K., & Yan, C. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0228-2 · Cited by 113
He, S., Liu, X., Yang, Y., Huang, W., Xu, S., Yang, S., Zhang, X., & Roberts, M. S. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09511.x · Cited by 119
Mahmoud, A. M., Desouky, E. M., Hozayen, W. G., Bin-Jumah, M. N., El‐Nahass, E., Soliman, H. A., & Farghali, A. A. (2019) · Biomolecules · doi:10.3390/biom9100528 · Cited by 125
“Furthermore, JAK2 has previously been demonstrated as a mediator of non-canonical TGFβ signaling [61].”
BackgroundCastello, L., Froio, T., Maina, M., Cavallini, G., Biasi, F., Leonarduzzi, G., Donati, A., Bergamini, E., Poli, G., & Chiarpotto, E. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.003 · Cited by 127
Transforming Growth Factor-β1 Suppresses Airway Hyperresponsiveness in Allergic Airway Disease
Alcorn, J. F., Rinaldi, L. M., Jaffe, E. F., van Loon, M., Bates, J. H. T., Janssen-Heininger, Y. M. W., & Irvin, C. G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-334oc · Cited by 118
NUAK1 promotes organ fibrosis via YAP and TGF-β/SMAD signaling
Zhang, T., He, X., Caldwell, L., Goru, S. K., Severino, L. U., Tolosa, M. F., Misra, P. S., McEvoy, C. M., Christova, T. Y., Liu, Y., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4028 · Cited by 124
Involvement of microtubules and Rho pathway in TGF‐β1‐induced lung vascular barrier dysfunction
Birukova, A. A., Birukov, K. G., Adyshev, D., Usatyuk, P. V., Natarajan, V., Garcia, J. G. N., & Verin, A. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20359 · Cited by 115
“Bar¼ 10 mm. et al., 2001; Wakefield and Roberts, 2002; Leask and Abraham, 2004).”
Myofibroblasts and lung fibrosis induced by carbon nanotube exposure
Dong, J., & Ma, Q. (2016) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0172-2 · Cited by 119
Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells
Carson, J. P., Ramm, G. A., Robinson, M. W., McManus, D. P., & Gobert, G. N. (2018) · Trends in Parasitology · doi:10.1016/j.pt.2018.02.005 · Cited by 120
Therapeutic effects of serum extracellular vesicles in liver fibrosis
Chen, L., Chen, R., Kemper, S., Cong, M., You, H., & Brigstock, D. R. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1461505 · Cited by 120
Ranjit, S., Dvornikov, A. S., Stakic, M., Hong, S.-H., Levi, M., Evans, R. M., & Gratton, E. (2015) · Scientific Reports · doi:10.1038/srep13378 · Cited by 123
The extracellular matrix in multiple sclerosis pathology
Van Horssen, J., Dijkstra, C. D., & De Vries, H. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04897.x · Cited by 112
“Transforming growth factor-b and its downstream mediator connective tissue growth factor are important modulatory proteins known to induce ECM production (Leask and Abraham 2004).”
BackgroundThe role of CTGF in diabetic retinopathy
Klaassen, I., van Geest, R. J., Kuiper, E. J., Noorden, C. J. F. V., & Schlingemann, R. O. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2014.10.016 · Cited by 119
“These pathological conditions have in common that tissue-specific wound healing responses are initiated, but that the wound healing process is not properly terminated, leading to pathological fibrosis [ 54, 66 ] .”
Background
Metadata
- Authors
- Leask, A., & Abraham, D. J.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 18
- Issue
- 7
- Pages
- 816-827
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2122808924
- Cited by
- 2,319
- References
- 153
- Citations by year
- 2026: 53 · 2025: 53 · 2024: 63 · 2023: 79 · 2022: 75 · 2021: 103 · 2020: 99 · 2019: 113 · 2018: 145 · 2017: 174 · 2016: 163 · 2015: 179 · 2014: 141 · 2013: 134 · 2012: 115
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Scleroderma Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- TGF-beta signaling, fibrosis, fibrogenesis, extracellular matrix deposition, connective tissue growth factor, ED-A fibronectin, TNF-α, interferon-gamma
- MeSH terms
- Animals, DNA-Binding Proteins, Fibronectins, Fibrosis, Gene Expression Regulation, Humans, Interferon-gamma, Tumor Necrosis Factor-alpha, Wound Healing, Signal Transduction, Trans-Activators, Transforming Growth Factor beta, Extracellular Matrix Proteins, Immediate-Early Proteins, Receptors, Transforming Growth Factor beta, MAP Kinase Signaling System, Intercellular Signaling Peptides and Proteins, Smad3 Protein, Smad4 Protein, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.